SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 87 filers reported holding SUTRO BIOPHARMA INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $59,843 | -66.2% | 12,953 | -61.9% | 0.00% | -100.0% |
| Q2 2022 | $177,000 | -48.4% | 34,041 | -18.4% | 0.00% | 0.0% |
| Q1 2022 | $343,000 | -39.0% | 41,716 | +10.4% | 0.00% | 0.0% |
| Q4 2021 | $562,000 | +165.1% | 37,800 | +236.7% | 0.00% | 0.0% |
| Q3 2021 | $212,000 | -67.3% | 11,228 | -67.8% | 0.00% | -50.0% |
| Q2 2021 | $648,000 | +125.0% | 34,877 | +21.7% | 0.00% | -50.0% |
| Q3 2020 | $288,000 | +23.6% | 28,661 | -4.4% | 0.00% | 0.0% |
| Q2 2020 | $233,000 | -42.0% | 29,980 | -23.8% | 0.00% | -60.0% |
| Q1 2020 | $402,000 | +31.4% | 39,365 | +41.5% | 0.01% | +400.0% |
| Q4 2019 | $306,000 | +61.1% | 27,818 | +32.8% | 0.00% | 0.0% |
| Q3 2019 | $190,000 | +33.8% | 20,951 | +67.7% | 0.00% | +100.0% |
| Q2 2019 | $142,000 | – | 12,495 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $39,611,000 | 19.08% |
| Samsara BioCapital, LLC | 1,675,579 | $36,377,000 | 3.66% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 185,000 | $4,016,000 | 2.33% |
| Affinity Asset Advisors, LLC | 200,000 | $4,342,000 | 2.30% |
| Altium Capital Management LP | 276,719 | $6,008,000 | 2.24% |
| FRAZIER MANAGEMENT LLC | 1,001,421 | $21,741,000 | 1.67% |
| BVF INC/IL | 1,854,162 | $40,254,000 | 1.58% |
| Asymmetry Capital Management, L.P. | 157,583 | $3,421,000 | 1.56% |
| Parkman Healthcare Partners LLC | 266,645 | $5,789,000 | 1.48% |
| AJU IB Investment Co., Ltd. | 175,000 | $3,799,000 | 1.44% |